Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 23andme, Anheart, Bluebird Bio, Boehringer, Bristol Myers, Burning Rock, Enterome, GSK, Karyopharm, Moderna, Nippon Kayaku, Obseva, Organon and Xoma.
